Objectives The primary objective of this study was the translation and validation of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire into Italian, denoted as AAV-PRO_ita. The secondary objective was to evaluate the impact of ANCA-associated vasculitis (AAV) on quality of life (QoL) and work impairment in a large cohort of Italian patients. Methods The study design took a prospective cohort study approach. First, the AAV-PRO was translated into Italian following the step guidelines for translations. The new AAV-PRO_ita questionnaire covered three disease domains: organ-specific and systemic symptoms and signs; physical function; and social and emotional impact. Second, Italian-speaking AAV patients were recruited from 17 Italian centres belonging to the Italian Vasculitis Study Group. Participants completed the AAV-PRO_ita questionnaire at three time points. Participants were also requested to complete the work productivity and activity impairment: general health questionnaire. Results A total of 276 AAV patients (56.5% women) completed the questionnaires. The AAV-PRO_ita questionnaire demonstrated a good internal consistency and test-retest reliability. Female AAV patients scored higher (i.e. worse) in all thee domains, especially in the social and emotional impact domain (P < 0.001). Patients on glucocorticoid therapy (n = 199) had higher scores in all domains, especially in the physical function domain (P < 0.001), compared with patients not on glucocorticoid therapy (n = 77). Furthermore, patients who had at least one relapse of disease (n = 114) had higher scores compared with those who had never had one (n = 161) in any domain (P < 0.05). Finally, nearly 30% of the patients reported work impairment. Conclusion The AAV-PRO_ita questionnaire is a new 29-item, disease-specific patient-reported outcome measuring tool that can be used in AAV research in the Italian language. Sex, glucocorticoids and relapsing disease showed the greatest impact on QoL.

Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire / Treppo E.; Isola M.; De Martino M.; Padoan R.; Giollo A.; Urban M.L.; Monti S.; Sartorelli S.; Fassio A.; Argolini L.M.; Marvisi C.; Gattamelata A.; Regola F.; Ferro F.; Cassone G.; Motta F.; Berti A.; Conticini E.; Guiducci S.; Matucci-Cerinic M.; Gullo A.L.; Manfredi A.; Frediani B.; Bortolotti R.; Selmi C.; Baldini C.; Franceschini F.; Conti F.; Caporali R.; Rossini M.; Dagna L.; Montecucco C.; Emmi G.; Schiavon F.; Salvarani C.; Quartuccio L.. - In: RHEUMATOLOGY ADVANCES IN PRACTICE. - ISSN 2514-1775. - ELETTRONICO. - 8:(2024), pp. rkae001.0-rkae001.0. [10.1093/rap/rkae001]

Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire

Padoan R.;Urban M. L.
Membro del Collaboration Group
;
Ferro F.;Matucci-Cerinic M.;Selmi C.;Caporali R.;Emmi G.;
2024

Abstract

Objectives The primary objective of this study was the translation and validation of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire into Italian, denoted as AAV-PRO_ita. The secondary objective was to evaluate the impact of ANCA-associated vasculitis (AAV) on quality of life (QoL) and work impairment in a large cohort of Italian patients. Methods The study design took a prospective cohort study approach. First, the AAV-PRO was translated into Italian following the step guidelines for translations. The new AAV-PRO_ita questionnaire covered three disease domains: organ-specific and systemic symptoms and signs; physical function; and social and emotional impact. Second, Italian-speaking AAV patients were recruited from 17 Italian centres belonging to the Italian Vasculitis Study Group. Participants completed the AAV-PRO_ita questionnaire at three time points. Participants were also requested to complete the work productivity and activity impairment: general health questionnaire. Results A total of 276 AAV patients (56.5% women) completed the questionnaires. The AAV-PRO_ita questionnaire demonstrated a good internal consistency and test-retest reliability. Female AAV patients scored higher (i.e. worse) in all thee domains, especially in the social and emotional impact domain (P < 0.001). Patients on glucocorticoid therapy (n = 199) had higher scores in all domains, especially in the physical function domain (P < 0.001), compared with patients not on glucocorticoid therapy (n = 77). Furthermore, patients who had at least one relapse of disease (n = 114) had higher scores compared with those who had never had one (n = 161) in any domain (P < 0.05). Finally, nearly 30% of the patients reported work impairment. Conclusion The AAV-PRO_ita questionnaire is a new 29-item, disease-specific patient-reported outcome measuring tool that can be used in AAV research in the Italian language. Sex, glucocorticoids and relapsing disease showed the greatest impact on QoL.
2024
8
0
0
Treppo E.; Isola M.; De Martino M.; Padoan R.; Giollo A.; Urban M.L.; Monti S.; Sartorelli S.; Fassio A.; Argolini L.M.; Marvisi C.; Gattamelata A.; Regola F.; Ferro F.; Cassone G.; Motta F.; Berti A.; Conticini E.; Guiducci S.; Matucci-Cerinic M.; Gullo A.L.; Manfredi A.; Frediani B.; Bortolotti R.; Selmi C.; Baldini C.; Franceschini F.; Conti F.; Caporali R.; Rossini M.; Dagna L.; Montecucco C.; Emmi G.; Schiavon F.; Salvarani C.; Quartuccio L.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1357614
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact